Profitability
This table compares PetVivo and Titan Medical’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| PetVivo | -902.82% | -4,813.07% | -281.78% |
| Titan Medical | N/A | -82.31% | -51.47% |
Institutional & Insider Ownership
24.5% of PetVivo shares are owned by institutional investors. Comparatively, 0.0% of Titan Medical shares are owned by institutional investors. 10.8% of PetVivo shares are owned by company insiders. Comparatively, 0.0% of Titan Medical shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
Earnings and Valuation
This table compares PetVivo and Titan Medical”s revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| PetVivo | $1.05 million | 22.67 | -$10.95 million | ($0.40) | -2.13 |
| Titan Medical | $17.63 million | 2.04 | $6.95 million | $0.05 | 6.32 |
Titan Medical has higher revenue and earnings than PetVivo. PetVivo is trading at a lower price-to-earnings ratio than Titan Medical, indicating that it is currently the more affordable of the two stocks.
Risk & Volatility
PetVivo has a beta of 0.66, indicating that its stock price is 34% less volatile than the S&P 500. Comparatively, Titan Medical has a beta of 1.26, indicating that its stock price is 26% more volatile than the S&P 500.
Summary
Titan Medical beats PetVivo on 8 of the 11 factors compared between the two stocks.
About PetVivo
PetVivo Holdings, Inc., a biomedical device company, engages in the manufacturing, commercializing, and licensing of medical devices and biomaterials for the treatment of afflictions and diseases in animals. Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. The company's pipeline products also include therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. was founded in 2009 and is headquartered in Minneapolis, Minnesota.
About Titan Medical
Titan Medical Inc. operates as a medical technology company. It focuses on the development and licensing of robotic assisted surgical technologies. The company is headquartered in Toronto, Canada.
Receive News & Ratings for PetVivo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PetVivo and related companies with MarketBeat.com's FREE daily email newsletter.
